CGENCompugen Ltd.

CGEN Stock Price, Valuation & Chart | Compugen Ltd.

Compare

$2.630+0.04 (+1.54%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology CGEN intrinsic value CGEN calculated fair value vs price

Overview Financials Dividends Ratios

CGEN Historical price chart

CGEN Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization248.67M

PE Ratio6.92

EPS0.38

Trading Volume127.74K

Today's High/Low2.63/2.56

Dividend Yield0.00

52 Week High/Low3.24/1.3

Shares Outstanding94.55M

CGEN Financial Statement

CGEN Analyst ratings

CGEN Analysis & performance metrics

CGEN Company profile

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the…

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody…

CGEN Management team

Name

Position

Yvonne Naughton

Head of Investor Relations & Corporate Communications

Pierre Ferre Ph.D.

Senior Vice President of Preclinical Development & Corporate Operations

Michelle Mahler M.D.

Chief Medical Officer

Zurit Levine Ph.D.

Senior Vice President of Strategic Collaborations

Eran Ben Dor

General Counsel & Corporate Secretary

Anat Cohen-Dayag Ph.D.CEO

Chief Executive Officer, President & Director

David Silberman CPACFO

Chief Financial Officer

Dorit Amitay

Vice President of Human Resources

Name

Position

Yvonne Naughton

Head of Investor Relations & Corporate Communications

Pierre Ferre Ph.D.

Senior Vice President of Preclinical Development & Corporate Operations

Michelle Mahler M.D.

Chief Medical Officer

Zurit Levine Ph.D.

Senior Vice President of Strategic Collaborations

Eran Ben Dor

General Counsel & Corporate Secretary

Anat Cohen-Dayag Ph.D.CEO

Chief Executive Officer, President & Director

David Silberman CPACFO

Chief Financial Officer

Dorit Amitay

Vice President of Human Resources

Management Team

Yvonne Naughton

Head of Investor Relations & Corporate Communications

Pierre Ferre Ph.D.

Senior Vice President of Preclinical Development & Corporate Operations

Michelle Mahler M.D.

Chief Medical Officer

Zurit Levine Ph.D.

Senior Vice President of Strategic Collaborations

Eran Ben Dor

General Counsel & Corporate Secretary

Anat Cohen-Dayag Ph.D.CEO

Chief Executive Officer, President & Director

David Silberman CPACFO

Chief Financial Officer

Dorit Amitay

Vice President of Human Resources

Management

Yvonne Naughton

Head of Investor Relations & Corporate Communications

Pierre Ferre Ph.D.

Senior Vice President of Preclinical Development & Corporate Operations

Michelle Mahler M.D.

Chief Medical Officer

Zurit Levine Ph.D.

Senior Vice President of Strategic Collaborations

Eran Ben Dor

General Counsel & Corporate Secretary

Anat Cohen-Dayag Ph.D.CEO

Chief Executive Officer, President & Director

David Silberman CPACFO

Chief Financial Officer

Dorit Amitay

Vice President of Human Resources

Total 8 executives

CGEN Frequently asked questions

What is Compugen Ltd. (CGEN) Stock Price?

Current stock price of Compugen Ltd. (CGEN) stock is $2.630. The stock price is +1.54% higher in the session. The intraday range can be seen from this page. Volume of Compugen Ltd. (CGEN) stock is 127.74K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Compugen Ltd. (CGEN) stock price going up or down today?

The stock price of Compugen Ltd. (CGEN) can change with earnings, company news, and overall market sentiment. Compugen Ltd. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Compugen Ltd. stock expensive at its current price?

Whether Compugen Ltd. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CGEN on this page is 6.92. EPS on this page is 0.38. Compare those figures with peers and growth expectations before deciding if the current Compugen Ltd. price is justified.

How has the stock price of Compugen Ltd. (CGEN) performed historically?

Historical performance for Compugen Ltd. (CGEN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CGEN reacted to past earnings and market events.

Should I buy Compugen Ltd. (CGEN) stock, at this price?

Buying Compugen Ltd. (CGEN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.